Skip to main content

Advertisement

ADVERTISEMENT

Transcatheter Aortic Valve Replacement

Original Contribution
05/06/2022

Martino Pepe, MD, PhD1;  Nicola Corcione, MD2;  Palma Luisa Nestola, MD1; Francesco Bedogni, MD3;  Sergio Berti, MD4;  Alberto Morello, MD2; Alessandro Iadanza, MD5;  Antonio L. Bartorelli, MD6,7;  Paolo Ferraro, MD8; Carmen Spaccarotella, MD9,10;  Gennaro Sardella, MD11;  Michele Cimmino, MD8-; Michele Albanese, MD8;  Marcello De Giosa, MMaths12;  Giuseppe Biondi-Zoccai, MD, MStat13,14;  Arturo Giordano, MD, PhD2

Martino Pepe, MD, PhD1;  Nicola Corci...
The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...
The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...
The differential outcomes...
05/06/2022
Journal of Invasive Cardiology
Original Contribution
05/01/2022

Salman Farhat, MBBS1; Abdallah El Sabbagh, MD1; Mohammed Al-Hijji, MD2; Keniel Pierre, MD1;  Nahyr S. Lugo-Fagundo, MD1; Yader Sandoval, MD2; Michael S. Gharacholou, MD1; Peter M. Pollak, MD1; Mandeep Singh, MD2; Mackram F. Eleid, MD2; Mohammed Al-Khouli, MD2; David R. Holmes, MD2; Mayra Guerrero, MD2; Rajiv Gulati, MD2; Malcolm Bell, MD2; Charanjit S. Rihal, MD2

Salman Farhat, MBBS1; Abdallah El Sab...
This study included consecutive patients who underwent PCI within 30 days before TAVR at Mayo Clinic. Vascular access was left to the discretion of the operator. Baseline demographics, procedural data, PCI outcomes, and subsequent...
This study included consecutive patients who underwent PCI within 30 days before TAVR at Mayo Clinic. Vascular access was left to the discretion of the operator. Baseline demographics, procedural data, PCI outcomes, and subsequent...
This study included consecutive...
05/01/2022
Journal of Invasive Cardiology
Original Contribution
04/01/2022

Itamar Loewenstein, MD1*;  Ilan Merdler, MD1*;  Aviram Hochstadt, MD1;  David Zahler, MD1;  Ariel Finkelstein, MD1;  Shmuel Banai, MD1;  Yan Topilsky, MD1;  Amir Halkin, MD1;  Maayan Konigstein, MD1;  Shmuel Bazan, MD1;  Issy Barbash, MD2;  Amit Segev, MD2;  Victor Guetta, MD2;  Haim Danenberg, MD3;  David Planner, MD3;  Katia Orvin, MD4;  Hana Assa-Vaknin, MD4;  Abid Assali, MD4;  Ran Kornowski, MD4;  Arie Steinvil, MD1

Itamar Loewenstein, MD1*;  Ilan Merdl...
The Medtronic Evolut Pro valve (EPV) is a new-generation self-expanding valve (SEV), particularly designed to reduce paravalvular leak (PVL) rates in transcatheter aortic valve replacement (TAVR). We aimed to compare the safety and efficacy...
The Medtronic Evolut Pro valve (EPV) is a new-generation self-expanding valve (SEV), particularly designed to reduce paravalvular leak (PVL) rates in transcatheter aortic valve replacement (TAVR). We aimed to compare the safety and efficacy...
The Medtronic Evolut Pro valve...
04/01/2022
Journal of Invasive Cardiology
Original Contribution
03/01/2022

Kinan Kneizeh, MD;  Anas Alnaimi, MD;  Timothee Noterdaeme, MD;  Jörg Schröder, MD;  Ertunc Altiok, MD;  Nikolaus Marx, MD;  Mohammad Almalla, MD

Kinan Kneizeh, MD;  Anas Alnaimi, MD;...
Transcatheter aortic valve implantation (TAVI) is nowadays the optimal therapeutic strategy in patients with severe aortic valve stenosis (AS). Consequently, percutaneous coronary intervention (PCI) of concomitant complex coronary artery...
Transcatheter aortic valve implantation (TAVI) is nowadays the optimal therapeutic strategy in patients with severe aortic valve stenosis (AS). Consequently, percutaneous coronary intervention (PCI) of concomitant complex coronary artery...
Transcatheter aortic valve...
03/01/2022
Journal of Invasive Cardiology
Original Contribution
03/01/2022

Ozan M. Demir, MD1*;  Jonathan Curio, MD2*;  Matteo Pagnesi, MD3;  Haseeb Rahman, MD1;  Satoru Mitomo, MD4;  Antonio Colombo, MD5;  Mei Chau, MD6;  Bernard Prendergast, MD1;  Azeem Latib, MD7,8

Ozan M. Demir, MD1*;  Jonathan Curio,...
This study sought to evaluate outcomes of TAVR for the treatment of severe aortic stenosis in nonagenarian patients.
This study sought to evaluate outcomes of TAVR for the treatment of severe aortic stenosis in nonagenarian patients.
This study sought to evaluate...
03/01/2022
Journal of Invasive Cardiology
Original Contribution
01/06/2022

Federico Conrotto, MD1*; Fabrizio D’Ascenzo, MD1*; Luca Franchin, MD1; Francesco Bruno, MD1; Mamas A. Mamas, MD2; Konstantinos Toutouzas, MD3; Thomas Cuisset, MD4; Florence Leclercq, MD5; Nicolas Dumonteil, MD6; Azeem Latib, MD7; Luis Nombela-Franco, MD8; Andreas Schaefer, MD, MHBA9; R. David Anderson, MD10; Laura Marruncheddu, MD11; Guglielmo Gallone, MD1; Ovidio De Filippo, MD1; Michele La Torre, MD1; Mauro Rinaldi, Prof12; Pierluigi Omedè, MD1; Stefano Salizzoni, MD1; Gaetano Maria De Ferrari, Prof1

Federico Conrotto, MD1*; Fabrizio D’A...
Federico Conrotto, MD and colleagues performed a systematic meta-analysis investigating patients undergoing TAVI with systematic BAV vs no BAV in RCT or in adjusted studies.
Federico Conrotto, MD and colleagues performed a systematic meta-analysis investigating patients undergoing TAVI with systematic BAV vs no BAV in RCT or in adjusted studies.
Federico Conrotto, MD and...
01/06/2022
Journal of Invasive Cardiology
Original Contribution
01/03/2022

Jesse Goitia, MD1; Derek Q. Phan, MD2; Ming-Sum Lee, MD, PhD1; Naing Moore, MD2; Prakash Mansukhani, MD2; Vicken Aharonian, MD2; Somjot S. Brar, MD, MPH2; Ray Zadegan, MD2

Jesse Goitia, MD1; Derek Q. Phan, MD2...
Invasive right heart catheterization provides valuable prognostic information in cases of severe aortic stenosis, but is not done routinely prior to transcatheter aortic valve replacement (TAVR). The authors sought to investigate the...
Invasive right heart catheterization provides valuable prognostic information in cases of severe aortic stenosis, but is not done routinely prior to transcatheter aortic valve replacement (TAVR). The authors sought to investigate the...
Invasive right heart...
01/03/2022
Journal of Invasive Cardiology
Original Contribution
01/03/2022

Saurabh Joshi, MD1;  Wassim Mosleh, MD2;  Mostafa R. Amer, MD3;  Mays Tawayha, MD2;  Jeffrey F. Mather, MS4;  Francis J. Kiernan, MD1;  Raymond G. McKay, MD1;  Bryan Piccirillo, MD1

Saurabh Joshi, MD1;  Wassim Mosleh, M...
Chronic steroid therapy is associated with higher vascular complication rates in patients undergoing TAVR. The effect of corticosteroids on aortic annular complications has not been directly assessed in this population.
Chronic steroid therapy is associated with higher vascular complication rates in patients undergoing TAVR. The effect of corticosteroids on aortic annular complications has not been directly assessed in this population.
Chronic steroid therapy is...
01/03/2022
Journal of Invasive Cardiology
Transcatheter Valve Implantation for Failed Surgical Aortic and Mitral Bioprostheses: A Single-Center Experience
Original Contribution
03/10/2020

Jerry Lipinski, MD1*; Sandeep M. Patel, MD2*; Toral R. Patel, MD3; Daniel Kobe, MD3, Petar Saric, MD, PharmD3; Muhammad Panhwar, MD3; Fahd Nadeem, MD4; Jun Li, MD4; Joshua R. Clevenger, MD4; Yasuhiro Ichibori, MD4; Anas Fares, MD4; Katherine Lang, BA5; Hiram G. Bezerra, MD, PhD4; Basar Sareyyupoglu, MD6; Benjamin Medalion, MD4; Salil Deo, MD4; Yakov Elgudin, MD, PhD4; Alan Markowitz, MD4; Daniel I. Simon, MD4; Marco A. Costa, MD, PhD4; Ankur Kalra, MD4; Guilherme F. Attizzani, MD4

Jerry Lipinski, MD1*; Sandeep M. Pate...
We share our center’s experience with the use of transcatheter valvular therapies in the setting of failed bioprostheses.
We share our center’s experience with the use of transcatheter valvular therapies in the setting of failed bioprostheses.
We share our center’s experience...
03/10/2020
Journal of Invasive Cardiology
Interaction Between Self-Expanding Transcatheter Heart Valves and Coronary Ostia: An Angiographically Based Analysis of the Evolut R/Pro Valve System
Original Contribution
03/10/2020

Thomas Couture, MS*; Laurent Faroux, MD, MSc*; Lucia Junquera, MD; David del Val, MD; Guillem Muntané-Carol, MD; Jerôme Wintzer-Wehekind, MD; Alberto Alperi, MD; Siamak Mohammadi, MD; Jean-Michel Paradis, MD; Robert Delarochellière, MD; Dimitri Kalavrouziotis, MD; Eric Dumont, MD; Josep Rodés-Cabau, MD

Thomas Couture, MS*; Laurent Faroux, ...
Abstract: Objectives. We sought to assess the position of the CoreValve Evolut R/Pro (Medtronic) with respect to the left coronary artery (LCA) ostium and evaluate the impact of implantation depth on this relationship. Methods. One hundred...
Abstract: Objectives. We sought to assess the position of the CoreValve Evolut R/Pro (Medtronic) with respect to the left coronary artery (LCA) ostium and evaluate the impact of implantation depth on this relationship. Methods. One hundred...
Abstract: Objectives. We sought...
03/10/2020
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement